𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effects of whole body hyperthermia on progression of friend virus-induced leukemia in mice

✍ Scribed by R. Steeves; V. Grant; N. Ghossein


Publisher
Elsevier Science
Year
1979
Tongue
English
Weight
83 KB
Volume
5
Category
Article
ISSN
0360-3016

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Effect of friend leukemia virus on megak
✍ W. M. Brown; A. A. Axelrad πŸ“‚ Article πŸ“… 1976 πŸ› John Wiley and Sons 🌐 French βš– 785 KB

## Abstract The thrombocytopenia that follows infection of C3H/Bi mice with Friend leukemia virus (FV) has been investigated. At various times after infection, megakaryocytes in bone marrow and spleen were collected on Nuclepore filters, stained with the Feulgen procedure, and counted. At the same

Shut-down of virus synthesis during prog
✍ Chalobon Yoosook πŸ“‚ Article πŸ“… 1982 πŸ› John Wiley and Sons 🌐 French βš– 799 KB

## Abstract Infection of (C57BL/6 Γ— DBA/2)F~1~ (BDF~1~) mice with 2,500 FFU of Friend virus complex (FV) resulted in erythroleukemia followed by recovery, at which time virus could not be detected in the spleens of mice, and with splenomegaly (progressor mice) or without splenomegaly (regressor mic

Influence of recombinant human interleuk
✍ Li Lu; Zhen Zhou; Bo Wu; Mang Xiao; Rong-Nian Shen; Douglas E. Williams; Young-J πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 French βš– 821 KB

Recombinant human (rhu) IL-7 was evaluated for its influence on disease progression in mice infected with the polycythemiainducing strain of the Friend virus complex (FVC). D B A I I mice were injected i.v. with FVC, and then treated S.C. with rhulL-7. IL-7 significantly prolonged survival time and

Immunotherapy of murine leukemia. XI. Di
✍ Carolyn L. Pettey; Jeffrey J. Collins πŸ“‚ Article πŸ“… 1984 πŸ› John Wiley and Sons 🌐 French βš– 868 KB

## Abstract It has previously been shown that DBA/2 mice protected against the development of Friend leukemia virus (FLV)^4^‐induced disease by the passive administration of heterologous antisera directed against disrupted virions or the major viral envelope glycoprotein (gp71) fail to undergo the